LUOPTIX

Welcome to the Brand page for “LUOPTIX”, which is offered here for In the statement, class 10 has been corrected per the restriction dated may 20, 2021, and per the fnote dated june 4, 2021.;pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans;the wording luoptix has no meaning in a foreign language.;applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body [ ; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes ];.

Its status is currently believed to be active. Its class is unavailable. “LUOPTIX” is believed to be currently owned by “Stada Arzneimittel AG”.


Owner:
STADA ARZNEIMITTEL AG
Owner Details
Description:
In the Statement, class 10 has been corrected per the Restriction dated May 20, 2021, and per the fnote dated June 4, 2021.;Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans;The wording LUOPTIX has no meaning in a foreign language.;Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body [ ; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes ];
Categories: STATEMENT